Chloroquine versus Sulfadoxine-Pyrimethamine for Treatment of Plasmodium falciparum Malaria in Savannakhet Province, Lao People's Democratic Republic: An Assessment of National Antimalarial Drug Recommendations

Clinical Infectious Diseases

Volumn 37, Issue 8, 2003, Pages 1021-1028

  Mayxay, Mayfong ^a,b   Newton, Paul N ^b,e   Khanthavong, Maniphono ^c   Tiengkham, Pongvongsa ^d   Phetsouvanh, Rattanaxay ^e   Phompida, Samlane ^c   Brockman, Alan ^f,g   White, Nicholas J ^b,e,f,g  

^a NATIONAL UNIVERSITY OF LAOS   (Laos)

^b MAHOSOT HOSPITAL   (Laos)

^c Ctr Malariology   (Laos)

^d Savannakhet Provincial Malaria Station   (Laos)

^e JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^f SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^g MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTESUNATE; CHLOROQUINE; FANSIDAR; MEFLOQUINE; PYRIMETHAMINE; QUININE;

ADULT; ARTICLE; CLINICAL TRIAL; COMA; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FEVER; GAMETOCYTE; HUMAN; IN VIVO STUDY; JAUNDICE; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME; VOMITING;

ADOLESCENT; ADULT; ANIMALS; ANTIMALARIALS; CHLOROQUINE; DRUG COMBINATIONS; DRUG RESISTANCE; FEMALE; HEALTH PLANNING GUIDELINES; HUMANS; LAOS; MALARIA, FALCIPARUM; MALE; PYRIMETHAMINE; SULFADOXINE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0142156161     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/377734     Document Type: Article

References (17)

1. Pillai DR, Labbe AC, Vanisaveth V, et al. Plasmodium falciparum malaria in Laos: chloroquine treatment outcome and predictive value of molecular markers. J Infect Dis 2001; 183:789-95.
2. White NJ. Drug resistance in malaria. Br Med Bull 1998; 54:703-15.
3. Guthmann JP, Kasparian S, Nathan N, et al. The efficacy of chloroquine for the treatment of acute uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic. Ann Trop Med Parasitol 2002; 96:553-7.
4. Schwobel B, Jordan S, Vanisaveth V, et al. Therapeutic efficacy of chloroquine plus sulphadoxine/pyrimethamine compared with monotherapy with either chloroquine or pyrimethamine/sulphadoxine in uncomplicated Plasmodium falciparum malaria in Laos. Trop Med Int Health 2003; 8:19-24.
5. World Health Organization. Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000; 94(Suppl 1):1-90.
6. Brockman A, Paul REL, Anderson TJC, et al. Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand. Am J Trop Med Hyg 1999; 60:14-21.
7. Silamut K, Hough R, Eggelte T, Pukrittayakamee S, Angus B, White NJ. A simple method for assessing quinine pretreatment in acute malaria. Trans R Soc Trop Med Hyg 1995; 89:665-7.
8. World Health Organization (WHO). Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission. WHO document no. WHO/MAL/94.1070. Geneva: WHO, 1996.
9. World Health Organization. Chemotherapy of malaria and resistance to antimalarials: report of a WHO Scientific Working Group. World Health Organ Tech Rep Ser 1973; 529:30-5.
10. White NJ. The assessment of antimalarial drug efficacy. Trends Parasitol 2002; 18:458-64.
11. Brockman A, Price R, van Vugt M, et al. Plasmodium falciparum antimalarial drug susceptibility on the north western border of Thailand during five years of extensive use of artesunate-mefloquine use. Trans R Soc Trop Med Hyg 2000; 94:537-44.
12. Nosten F, van Vugt M, Price R, et al. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet 2000; 356:297-302.
13. Smithuis FM, Monti F, Grundi M, et al. In vivo sensitivity of Plasmodium falciparum to chloroquine, sulphadoxine-pyrimethamine, and mefloquine in Rakhine State, Western Myanmar. Trans R Soc Trop Med Hyg 1997; 91:468-72.
14. Puta C, Manyando C. Enhanced gametocyte production in Fansidar-treated Plasmodium falciparum malaria patients: implications for malaria transmission control programmes. Trop Med Int Health 1997; 2:227-9.
15. Tjitra E, Suprianto S, Currie BJ, Morris PS, Saunders JR, Anstey NM. Therapy of uncomplicated falciparum malaria: a randomized trial comparing artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone in Irian Jaya, Indonesia. Am J Trop Med Hyg 2001; 65:309-17.
16. Von Seidlein L, Jawara M, Coleman R, Doherty T, Walraven G, Targett G. Parasitaemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria. Trop Med Int Health 2001; 6:92-8.
17. Price RN, Nosten F, Luxemburger C, et al. Effects of artemisinin derivatives on malaria transmissibility. Lancet 1996; 347:1654-8.